Reduced IL-1Ra/IL-1 ratio in ultraviolet B-exposed skin of patients with polymorphic light eruption

Experimental Dermatology

Volumn 18, Issue 3, 2009, Pages 212-217

  Janssens, A S ^a   Pave, S ^a   Tensen, C P ^a   Teunissen, M B M ^b   Out Luiting, J J ^a   Willemze, R ^a   de Gruijl, F R ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

Cytokines; IL 1; Polymorphic light eruption; Ultraviolet B

Indexed keywords

INTERLEUKIN 1; INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 1 RECEPTOR ALPHA; INTERLEUKIN 1ALPHA; INTERLEUKIN 1BETA; INTERLEUKIN 4; INTERLEUKIN 8; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MONOCYTE CHEMOTACTIC PROTEIN 1; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ADULT; ALLERGIC REACTION; ARTICLE; BLISTER; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DISEASE PREDISPOSITION; DOSE RESPONSE; FEMALE; HUMAN; INNATE IMMUNITY; LANGERHANS CELL; LEUKOCYTE MIGRATION; MALE; PHOTOALLERGY; PHOTODERMATOSIS; PROTEIN EXPRESSION; RADIATION DOSE; RADIATION EXPOSURE; SKIN ALLERGY; ULTRAVIOLET B RADIATION;

ADULT; CASE-CONTROL STUDIES; CELL MOVEMENT; FEMALE; HUMANS; INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN; INTERLEUKIN-1; INTERLEUKIN-1ALPHA; INTERLEUKIN-1BETA; INTERLEUKIN-8; LANGERHANS CELLS; MALE; MIDDLE AGED; NEUTROPHILS; PHOTOSENSITIVITY DISORDERS; SKIN; TUMOR NECROSIS FACTOR-ALPHA; ULTRAVIOLET RAYS;

EID: 63149154719     PISSN: 09066705     EISSN: 16000625     Source Type: Journal    
DOI: 10.1111/j.1600-0625.2008.00785.x     Document Type: Article

References (29)

1. Pao C, Norris P G, Corbett M et al. Polymorphic light eruption: prevalence in Australia and England. Br J Dermatol 1994: 130: 62-64.
2. Ros A M, Wennersten G. Current aspects of polymorphous light eruptions in Sweden. Photodermatol 1986: 3: 298-302.
3. Norris P G, Hawk J L. Polymorphic light eruption. Photodermatol Photoimmunol Photomed 1990: 7: 186-191.
4. Palmer R A, Friedmann P S. Ultraviolet radiation causes less immunosuppression in patients with polymorphic light eruption than in controls. J Invest Dermatol 2004: 122: 291-294.
5. van de Pas C B, Kelly D A, Seed P T et al. Ultraviolet-radiation-induced erythema and suppression of contact hypersensitivity responses in patients with polymorphic light eruption. J Invest Dermatol 2004: 122: 295-299.
6. Janssens A S, Pavel S, Out-Luiting J J et al. Normalized ultraviolet (UV) induction of Langerhans cell depletion and neutrophil infiltrates after artificial UVB hardening of patients with polymorphic light eruption. Br J Dermatol 2005: 152: 1268-1274.
7. Kolgen W, van Weelden H, Den Hengst S et al. CD11b+ cells and ultraviolet- B-resistant CD1a+ cells in skin of patients with polymorphous light eruption. J Invest Dermatol 1999: 113: 4-10.
8. Strickland I, Rhodes L E, Flanagan B F et al. TNF-alpha and IL-8 are upregulated in the epidermis of normal human skin after UVB exposure: correlation with neutrophil accumulation and E-selectin expression. J Invest Dermatol 1997: 108: 763-768.
9. Teunissen M B, Piskin G, di Nuzzo S et al. Ultraviolet B radiation induces a transient appearance of IL-4+ neutrophils, which support the development of Th2 responses. J Immunol 2002: 168: 3732-3739.
10. Schornagel I J, Sigurdsson V, Nijhuis E H et al. Decreased neutrophil skin infiltration after UVB exposure in patients with polymorphous light eruption. J Invest Dermatol 2004: 123: 202-206.
11. Moser B, Willimann K. Chemokines: Role in inflammation and immune surveillaIce. Ann Rheum Dis 2004: 63 (Suppl. 2): ii84-ii89.
12. Barr R M, Walker S L, Tsang W et al. Suppressed alloantigen presentation, increased TNF-alpha, IL-1, IL-1Ra, IL-10, and modulation of TNF-R in UV-irradiated human skin. J Invest Dermatol 1999: 112: 692-698.
13. Shahbakhti H, Watson R E, Azurdia R M et al. Influence of eicosapentaenoic acid, an omega-3 fatty acid, on ultraviolet-B generation of prostaglandin-E2 and proinflammatory cytokines interleukin-1 beta, tumor necrosis factor-alpha, interleukin-6 and interleukin-8 in human skin in vivo. Photochem Photobiol 2004: 80: 231-235.
14. Skov L, Hansen H, Allen M et al. Contrasting effects of ultraviolet A1 and ultraviolet B exposure on the induction of tumour necrosis factor-alpha in human skin. Br J Dermatol 1998: 138: 216-220.
15. Averbeck M, Beilharz S, Bauer M et al. In situ profiling and quantification of cytokines released during ultraviolet B-induced inflammation by combining dermal microdialysis and protein microarrays. Exp Dermatol 2006: 15: 447-454.
16. Kolgen W, van Meurs M, Jongsma M et al. Differential expression of cytokines in UVB-exposed skin of patients with polymorphous light eruption: Correlation with Langerhans cell migration and immunosuppression. Arch Dermatol 2004: 140: 295-302.
17. Wackernagel A, Back B, Quehenberger F et al. Langerhans cell resistance, CD11b+ cell influx, and cytokine mRNA expression in skin after UV exposure in patients with polymorphous light eruption as compared with healthy control subjects. J Invest Dermatol 2004: 122: 1342-1344.
18. Cumberbatch M, Dearman R J, Kimber I. Interleukin 1 beta and the stimulation of Langerhans cell migration: Comparisons with tumour necrosis factor alpha. Arch Dermatol Res 1997: 289: 277-284.
19. Cumberbatch M, Dearman R J, Groves R W et al. Differential regulation of epidermal langerhans cell migration by interleukins (IL)-1alpha and IL-1beta during irritant- and allergen-induced cutaneous immune responses. Toxicol Appl Pharmacol 2002: 182: 126-135.
20. Beissert S, Schwarz T. Mechanisms involved in ultraviolet light-induced immunosuppression. J Investig Dermatol Symp Proc 1999: 4: 61-64.
21. Cumberbatch M, Bhushan M, Dearman R J et al. IL-1beta-induced Langerhans' cell migration and TNF-alpha production in human skin: regulation by lactoferrin. Clin Exp Immunol 2003: 132: 352-359.
22. Beissert S, Hosoi J, Stratigos A et al. Differential regulation of epidermal cell tumor-antigen presentation by IL-1alpha and IL-1beta. J Invest Dermatol 1998: 111: 609-615.
23. Lee S C, Brummet M E, Shahabuddin S et al. Cutaneous injection of human subjects with macrophage inflammatory protein-1 alpha induces significant recruitment of neutrophils and monocytes. J Immunol 2000: 164: 3392-3401.
24. Gordon P M, Saunders P J, Diffey B L et al. Phototesting prior to narrowband (TL-01) ultraviolet B phototherapy. Br J Dermatol 1998: 139: 811-814.
25. Carson R T, Vignali D A. Simultaneous quantitation of 15 cytokines using a multiplexed flow cytometric assay. J Immunol Methods 1999: 227: 41-52.
26. Arend W P, Welgus H G, Thompson R C et al. Biological properties of recombinant human monocyte-derived interleukin 1 receptor antagonist. J Clin Invest 1990: 85: 1694-1697.
27. Hirao T, Aoki H, Ichikawa H et al. Characterization of an interleukin 1 receptor antagonist protein released from ultraviolet-irradiated epidermal sheet. J Dermatol Sci 1997: 14: 189-198.
28. Terui T, Hirao T, Sato Y et al. An increased ratio of interleukin-1 receptor antagonist to interleukin-1alpha in inflammatory skin diseases. Exp Dermatol 1998: 7: 327-334.
29. Schmidt E, Mittnacht A, Schomig H et al. Detection of IL-1 alpha, IL-1 beta and IL-1 receptor antagonist in blister fluid of bullous pemphigoid. J Dermatol Sci 1996: 11: 142-147.